Vaccine Code Set Release Notes - 9/6/2023

"Centers for Disease Control and Prevention" <no-reply@xxxxxxxxxxxxxxxxxxxx> · Wed, 06 Sep 2023 08:46:05 -0700

If this is a forwarded email, subscribe now to receive future updates on this topic.

You are subscribed to one or more CDC code set email subscription services. Subscription links are available on each of the pages below.
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=vg
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=mvx
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=tradename
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=ndc
https://www2.cdc.gov/vaccines/iis/iisstandards/ndc_tableaccess.asp
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cpt
https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvxvis
https://www2a.cdc.gov/vaccines/iis/iisstandards/ndc_tableaccess.asp
https://www.cdc.gov/vaccines/programs/iis/code-sets/vis-barcode-lookup-table.html

Vaccine Code Set  Update Publication Date: September  06, 2023 

Release Notes:  This  release includes only CDC IIS Data Code Set website updates and a new Fall 2023  COVID-19 vaccine codes and crosswalk table.   The file updates for vaccine codes and maps will be provided at a later  date after the FDA authorizes the Fall 2023 COVID-19 vaccines.

Vaccine Code Set Updates

CDC’s IIS Code Set website  has been updated to include tables for all three respiratory virus Fall 2023 vaccine  codes.  They are now presented in the  following order with links directly to each table.
Fall 2023 COVID-19 Codes and Crosswalk
Other COVID-19 Vaccine Related Codes and Links
Respiratory Syncytial Virus (RSV) Codes and Crosswalk
2023/2024 Seasonal Influenza Codes and Crosswalk

(NEW) Fall  2023 COVID-19 Codes and Crosswalk Table

 The  new Fall 2023 COVID-19 Table is introduced at this time as a preview of  the potential codes that will be activated and published in the vaccine code  set files once the FDA BLA licensure and   Emergency Use Authorizations (EUA) are received.

 All  the new Fall COVID-19 vaccines will be for SARS-CoV-2 virus strain Omicron  XBB.1.5.

 The  table which includes additional columns beyond those shown below is available  on CDC’s IIS Data Code Set webpage (IIS  Data Code Sets | CDC).

 As noted above, the vaccine code set files  are not being updated with this information at this time. A separate vaccine code  set release and release notes will be provided when those codes are published.

      FALL    2023 COVID-19 CODES AND CROSSWALK

      MVX Product    Label Tradename (*) CVX    Code CVX    Short Description UoS    NDC10

      UoS NDC11 Packaging UoU    NDC10

      UoU NDC11 Age    Cohort;

      Presentation CPT    Code CPT    Description
Pfizer

      (PFR) COMIRNATY (COVID-19 Vaccine, mRNA, 2023-2024 Formula) 309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL 0069-2362-10

      00069-2362-10 CARTON, 10 SINGLE-DOSE VIALS 0069-2362-01

      00069-2362-01 Ages 12 years and older; 

      VIAL, SINGLE-DOSE, 30 mcg/0.3 mL 91320 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3    mL dosage, tris-sucrose formulation, for intramuscular use
Pfizer

      (PFR) COMIRNATY (COVID-19 Vaccine, mRNA, 2023-2024 Formula) 309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL 0069-2392-10

      00069-2392-10 CARTON, 10 PRE-FILLED SYRINGES 0069-2392-01

      00069-2392-01 Ages 12 years and older; 

      SYRINGE, PRE-FILLED, 30 mcg/0.3 mL 91320 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3    mL dosage, tris-sucrose formulation, for intramuscular use
Pfizer

      (PFR) Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) 310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL 59267-4331-2

      59267-4331-02 CARTON, 10 SINGLE-DOSE VIALS 59267-4331-1

      59267-4331-01 Ages    5 through 11 years; 

      VIAL, SINGLE-DOSE, 10 mcg/0.3 mL 91319 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike    protein, 10 mcg/0.3 mL dosage, tris-sucrose    formulation, for intramuscular use
Pfizer

      (PFR) Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) 308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL 59267-4315-2

      59267-4315-02 CARTON, 10 MULTI-DOSE VIALS 59267-4315-1

      59267-4315-01 Ages 6 months through 4 years; 

      VIAL, MULTI-DOSE, 3 DOSES, 3mcg / 0.3 mL AFTER DILUTION 91318 Severe    acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease    [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.3 mL dosage,    tris-sucrose formulation, for intramuscular use
Novavax

      (NVX) Novavax COVID-19 Vaccine, Adjuvanted 313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL 80631-105-02

      80631-0105-02 CARTON, 2 MULTI-DOSE VIALS 80631-105-01

      80631-0105-01 Ages 12 years and older;

      VIAL, MULTI-DOSE, 5 DOSES, 5 mcg/0.5 mL  91304 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, recombinant spike protein    nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage,    for intramuscular use
Moderna

      (MOD) Spikevax 312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL 80777-102-95

      80777-0102-95 CARTON,    10 SINGLE-DOSE VIALS 80777-102-04

      80777-0102-04 Ages 12 years and older;

      VIAL, SINGLE-DOSE, 50 mcg/0.5 mL   91322 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for    intramuscular use
Moderna

      (MOD) Spikevax 312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL 80777-102-96

      80777-0102-96 CARTON, 10 PRE-FILLED SYRINGES 80777-102-01

      80777-0102-01 Ages    12 years and older;

      SYRINGE, PRE-FILLED, 50 mcg/0.5 mL   91322 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for    intramuscular use
Moderna

      (MOD) Spikevax 312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL 80777-102-93

      80777-0102-93 CARTON,    10 BLISTER-SEALED PRE-FILLED SYRINGES 80777-102-01

      80777-0102-01 Ages    12 years and older;

      SYRINGE, PRE-FILLED, 50 mcg/0.5 mL 91322 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for    intramuscular use
Moderna

      (MOD) Moderna    COVID-19 Vaccine 311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL 80777-287-92

      80777-0287-92 CARTON,    10 SINGLE-DOSE VIALS 80777-287-07

      80777-0287-07 Ages    6 months through 11 years;

      VIAL, SINGLE-DOSE, 25 mcg/0.25 mL 91321 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)    (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage,    for intramuscular use
(*) Product Label Tradename:     If the manufacturer name is included in the tradename, the vaccine    product is to be provided under Emergency Use Authorization (EUA), once FDA    EUA issuance is received.  Other    tradenames are for vaccine products to be provided under BLA licensure, once    approved.

Centers for Disease Control and Prevention
1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  